Skip to main content
SpringerLink
Log in

Cotransfection of Survivin and CD44v3 Short Hairpin RNAs Affects Proliferation, Apoptosis, and Invasiveness of Colorectal Cancer

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Introduction

Colorectal cancer is one of the common malignant tumors in humans, and the incidence rate is gradually increasing year by year. Survivin and CD44v3 are ideal targets for gene therapy due to their overexpression in colorectal cells. Studies show that downregulation of survivin could promote apoptosis and depress proliferation, and reduction of CD44v3 expression could inhibit tumor invasive capacity. It is difficult to achieve satisfactory curative effect.

Objective

In this study, we use survivin and CD44v3 short hairpin RNAs (shRNA) combined transfection into colorectal cancer cell line SW480 to investigate its effects on the cell apoptosis, proliferation and invasiveness.

Methods

ShRNA plasmids targeting survivin and CD44v3 were singly or co-transfected into SW480 cells.

Results

The co-transfection group exhibited the most significant inhibitory effect on cell growth (P < 0.05) and the highest apoptosis rate (P < 0.05). In addition, the invasive capacity in the co-transfected group was the least. The tumor inhibition rate of the cotransfected group in xenograft tumor mice was significantly higher than other groups (P < 0.05). Moreover, the microvessel density of the co-transfected group was significantly decreased compared with other groups (P < 0.05).

Conclusion

These results suggest combined transfection of survivin shRNA and CD44v3 shRNA may produce a synergistic effect on gene therapy in colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Kasschau KD, Carrington JC. A counterdefensive strategy of plant viruses: suppression of post transcriptional gene silencing. Cell. 1998;95:461–470.

    Article  PubMed  CAS  Google Scholar 

  2. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol. 2003;9:974–977.

    PubMed  CAS  Google Scholar 

  3. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet. 2003;362:205–209.

    Article  PubMed  CAS  Google Scholar 

  4. Kuniyasu H, Oue N, Tsutsumi M, Tahara E, Yasui W. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant Exon3. Clin Cancer Res. 2001;7:4067–4072.

    PubMed  CAS  Google Scholar 

  5. Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S. Frequent expression of the high molecular, 673-bp CD44v3, v8–10 variant in colorectal adenomas and carcinomas. Int J Mol Med. 2009;24:677–683.

    Article  PubMed  CAS  Google Scholar 

  6. Kuniyasu H, Chihara Y, Kubozoe T, Takahashi T. Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer. Int J Mol Med. 2002;10:3.

    Google Scholar 

  7. Zaffaroni N, Pennati M, Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med. 2005;9:360–372.

    Article  PubMed  CAS  Google Scholar 

  8. Kopp R, Fichter M, Assert R, Pfeiffer AF, Classen S. Butyrate-induced alteration of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells. Int J Mol Med. 2009;23:639–649.

    Article  PubMed  CAS  Google Scholar 

  9. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6:127–134.

    PubMed  CAS  Google Scholar 

  10. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46:645–650.

    Article  PubMed  CAS  Google Scholar 

  11. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277:4589–4592.

    Article  PubMed  CAS  Google Scholar 

  12. Knudson W, Chow G, Knudson CB. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002;21:15–23.

    Article  PubMed  CAS  Google Scholar 

  13. Altieri DC. Survivin and apoptosis control. Adv Cancer Res. 2003;88:31–52.

    Article  PubMed  CAS  Google Scholar 

  14. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004;23:2825–2837.

    Article  PubMed  CAS  Google Scholar 

  15. Wheatley SP, Henzing AJ, Dodson H, Khaled W, Earnshaw WC. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J Biol Chem. 2004;279:5655–5660.

    Article  PubMed  CAS  Google Scholar 

  16. Kuniyasu H, Chihara Y, Kubozoe T, Takahashi T. Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer. Int J Mol Med. 2002;10:333–337.

    PubMed  Google Scholar 

  17. Miyazaki T, Atarashi Y, Yasumura S, et al. Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1. Gastroenterol Hepatol. 2006;21:84–91.

    Article  CAS  Google Scholar 

  18. Kim KS, Kim DS, Chung KH, et al. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1–3, endostatin, and saxatilin genes. Cancer Gene Ther. 2006;13:563–571.

    Article  PubMed  CAS  Google Scholar 

  19. Zheng C, Lin L, Ma Y, Jiang W, Ma T, Hu G. Expression of survivin protein during pathogenesis of human colon mucosa. World Chin J Digestol. 2002;10:1052–1053.

    CAS  Google Scholar 

  20. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol. 2003;9:974–977.

    PubMed  CAS  Google Scholar 

  21. Watson AJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol. 2006;57:107–121.

    Article  PubMed  Google Scholar 

  22. Rödel F, Hoffmann J, Grabenbauer GG, et al. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol. 2002;178:426–435.

    Article  PubMed  Google Scholar 

  23. Liu Z, Zheng C, Yu W. Impact of survivin shRNA on proliferation and cell cycle of colon cancer SW480 cells. J Oncol. 2008;14:186–189.

    CAS  Google Scholar 

  24. Xiong Y, Wang A, Guo W. Biological behavior of colorectal carcinoma Lovo cells after stable transfection of survivin-targeting shRNA expression vector. J Chin Pract Diagn Ther. 2009;23:741–743.

    Google Scholar 

  25. Leng S, Liu Y, Zhao H, Sun G, Wang R. Inhibition of gastric cancer BGC-823 cell proliferation by small interfering RNA specific to survivin gene in vitro. Chin J Microecol. 2010;22:805–807.

    CAS  Google Scholar 

  26. Ai Z, Feng Y. Effects of survivin on motility and invasion in endometrial cancer cells. Chin J Cancer Prev Treat. 2010;17:261–265.

    CAS  Google Scholar 

  27. Liu Y, Shen W, Lu L, Ge H, Gai X, Zhao X. Knockdown of survivin using siRNA promotes prostatic apoptosis in cancer cell DU145. Chin J Pathophysiol. 2010;26:1474–1478.

    CAS  Google Scholar 

  28. Ceng L, Wu S, Wang H, Chen S, Chen Y. Research on the effect of survivin on apoptosis and proliferation of lung cancer cell by RNAi. Prog Mod Biomed. 2009;9:271–273.

    Google Scholar 

  29. Mayer B, Jauch KW, Günthert U, et al. De novo expression of CD44 and survival in gastric cancer. Lancet. 1993;342:1019–1022.

    Article  PubMed  CAS  Google Scholar 

  30. Wang SJ, Wreesmann VB, Bourguignon LY. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 2007;29:550–558.

    Article  PubMed  Google Scholar 

  31. Gadd SL, Hobbs G, Miller MR. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002;66:233–243.

    Article  PubMed  CAS  Google Scholar 

  32. Zhou W, Dai Q, Deng X, Zhang S, Zhang X. Expressions of survivin and Bcl-2 in gastric carcinoma and their significance. J Oncol. 2009;15:549–551.

    CAS  Google Scholar 

  33. Zhang D, Yang H, Zhu W, Feng Z, Deng H, Wei Y. Construction and identification of eukaryotic co-expression Plasmid carrying FUS1 and recombinant human IL-12 genes and its effect on apoptosis of A549 cells. J Sichuan Univ (Med Sci Ed). 2009;40:569–574.

    CAS  Google Scholar 

  34. Kim KS, Kim DS, Chung KH, Park YS. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1–3, endostatin, and saxatilin genes. Cancer Gene Ther. 2006;13:563–571.

    Article  PubMed  CAS  Google Scholar 

  35. Zhou J, Schmid T, Schniizer S, et al. Tumor hypoxia and cancer progression. Cancer Lett. 2006;237:10–21.

    Article  PubMed  CAS  Google Scholar 

  36. Hammond EM, Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun. 2005;331:718–725.

    Article  PubMed  CAS  Google Scholar 

  37. Lin G, Stern R. Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett. 2001;163:95–101.

    Article  PubMed  CAS  Google Scholar 

  38. Coma S, Noe V, Lavarino C, et al. Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides. 2004;14:100–113.

    Article  PubMed  CAS  Google Scholar 

  39. Stern R, Shuster S, Wiley TS, Formby B. Hyaluronidase can modulate expression of CD44. Exp Cell Res. 2001;266:167–176.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

No financial relationships with a commercial entity producing health-care related products and/or services relevant to this article.

Author information

Authors and Affiliations

  1. The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin, 150086, China

    Zhonghong Liu, Juan Li, Jun Xu & Bingrong Liu

  2. Yuebei people’s hospital, Southern Road of Huimin, Wujiang District, Shaoguan, Guangdong province, China

    Yonghang Guo

Authors
  1. Zhonghong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yonghang Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bingrong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhonghong Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Z., Guo, Y., Li, J. et al. Cotransfection of Survivin and CD44v3 Short Hairpin RNAs Affects Proliferation, Apoptosis, and Invasiveness of Colorectal Cancer. Dig Dis Sci 58, 1590–1601 (2013). https://doi.org/10.1007/s10620-012-2539-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2539-z

Keywords

Search

Navigation